Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. (Q54480739)

30 May 2018

title

Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. (English)

1 reference

30 May 2018

author

Hiroaki Adachi

3

1 reference

30 May 2018

Gen Sobue

13

object named as

Gen Sobue

1 reference

30 May 2018

Makoto Minamiyama

1

1 reference

30 May 2018

Masahisa Katsuno

2

1 reference

30 May 2018

Hideki Doi

4

1 reference

30 May 2018

Naohide Kondo

5

1 reference

30 May 2018

Madoka Iida

6

1 reference

30 May 2018

Shinsuke Ishigaki

7

1 reference

30 May 2018

Yusuke Fujioka

8

1 reference

30 May 2018

Shinjiro Matsumoto

9

1 reference

30 May 2018

Yu Miyazaki

10

1 reference

30 May 2018

Fumiaki Tanaka

11

1 reference

30 May 2018

Hiroki Kurihara

12

1 reference

30 May 2018

language of work or name

English

0 references

publication date

30 September 2012

1 reference

30 May 2018

published in

Nature Medicine

1 reference

30 May 2018

volume

18

1 reference

30 May 2018

issue

10

1 reference

30 May 2018

page(s)

1531-1538

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1038/nm.2932

exact match

0 references

cites work

Huntington's disease: from molecular pathogenesis to clinical treatment

1 reference

Diseases of unstable repeat expansion: mechanisms and common principles

21 January 2018

1 reference

Perspectives of Kennedy's disease

21 January 2018

1 reference

Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).

21 January 2018

1 reference

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

21 January 2018

1 reference

Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.

21 January 2018

1 reference

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

21 January 2018

1 reference

Polyglutamine diseases: emerging concepts in pathogenesis and therapy

21 January 2018

1 reference

Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

21 January 2018

1 reference

Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy

21 January 2018

1 reference

Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.

21 January 2018

1 reference

Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics

21 January 2018

1 reference

Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy.

21 January 2018

1 reference

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

21 January 2018

1 reference

Histone deacetylase inhibitors as therapeutics for polyglutamine disorders

21 January 2018

1 reference

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

21 January 2018

1 reference

CRE-mediated transcription is increased in Huntington's disease transgenic mice.

21 January 2018

1 reference

Transcriptional abnormalities in Huntington disease

21 January 2018

1 reference

Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy

21 January 2018

1 reference

CGRP and its receptors provide new insights into migraine pathophysiology

21 January 2018

1 reference

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems

21 January 2018

1 reference

Regulation of signal transduction by calcitonin gene-related peptide receptors

21 January 2018

1 reference

New insights into the molecular actions of serotonergic antimigraine drugs.

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review

21 January 2018

1 reference

Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.

21 January 2018

1 reference

JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport

21 January 2018

1 reference

Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice

21 January 2018

1 reference

Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis

21 January 2018

1 reference

Pre-symptomatic alterations in subcellular betaCGRP distribution in motor neurons precede astrogliosis in ALS mice.

21 January 2018

1 reference

Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells

21 January 2018

1 reference

Pain pharmacology in migraine: focus on CGRP and CGRP receptors

21 January 2018

1 reference

Involvement of cAMP-dependent protein kinase and pertussis toxin-sensitive G-proteins in CGRP mediated JNK activation in human neuroblastoma cell line

21 January 2018

1 reference

JNK signalling: a possible target to prevent neurodegeneration.

21 January 2018

1 reference

Implication of the JNK pathway in a rat model of Huntington's disease

21 January 2018

1 reference

JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities

21 January 2018

1 reference

Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk

21 January 2018

1 reference

Neuropeptides in migraine and cluster headache

21 January 2018

1 reference

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

21 January 2018

1 reference

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

21 January 2018

1 reference

Elevated sympathetic nervous activity in mice deficient in alphaCGRP

21 January 2018

1 reference

CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.

21 January 2018

1 reference

17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

21 January 2018

1 reference

Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

12 December 2020

X-linked recessive bulbospinal neuronopathy. A clinicopathological study

1 reference

12 December 2020

The effect of castration on calcitonin gene-related peptide in spinal motor neurons

1 reference

12 December 2020

Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women

1 reference

12 December 2020

Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries

1 reference

12 December 2020

Mitochondrial abnormalities in spinal and bulbar muscular atrophy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.2932

1 reference

30 May 2018

PubMed ID

23023499

1 reference

30 May 2018